References
Powell M. Subarachnoid haemorrhage. Prescr J 1990; 30(4): 173–9
Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke 1994 Nov; 25(11): 2315–28
Subarachnoid hemorrhage — saccular aneurysm. In: Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 2252–4
Macdonald RL. Drug treatment of aneurysmal subarachnoid haemorrhage. CNS Drugs 1996 Apr; 5(4): 264–77
Vermeulen M, Lindsay KW, Cheah MF, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 1984; 311: 432–7
Robinson MJ, Teasdale GM. Calcium antagonists in the management of subarachnoid haemorrhage. Cerebrovasc Brain Metab Rev 1990; 2: 205–26
Findlay JM, Kassell NF, Weir BKA, et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995; 37: 168–78
Dorsch N, Kassell N, Means E, et al. European-Australasian trial of tirilazad mesylate after aneurysm rupture. Presented at: The 4th International Workshop in Cerebrovascular Surgery: 1995 Jun 11–14; Chicago, IL
Clarke WM, Hazel S, Coull BM. Lazaroids: CNS pharmacology and current research. Drugs 1995 Dec; 50(6): 971–83
Rights and permissions
About this article
Cite this article
Aim to prevent rebleeding and minimise neurological deficit in aneurysmal subarachnoid haemorrhage. Drugs Ther. Perspect 8, 8–11 (1996). https://doi.org/10.2165/00042310-199608100-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199608100-00003